Cancer has become a part of American society in recent years with 14.5 million Americans determined to have been battling with the disease as of 2014. 40% of Americans are likely to be diagnosed with cancer at one point in their life, and the National Cancer Institute approximates that 19 million people will suffer from the disease by the year 2024. The future, however, looks more promising owing to the advancements in medical technology brought about by such companies as Tempus. Tempus was co-founded by Eric Lefkofsky and is one of the businesses that are at the forefront of developing data-enabled precision medicine.
Despite the hullabaloo made over the development of electronic health record systems, the healthcare sector has not yet come up to the level of modern technology. It took the diagnosis of breast cancer on Eric Lefkofsky’s wife for him to discover the gap that exists in the medical field as pertains the collection of data and adoption of digital technology in the industry. The massive amounts of patient information collected in the medical centers had not been well corralled to put it into practical use. Tempus was founded to fill this gap in technology adoption and advancement in healthcare sector. The company aims to revolutionize cancer treatment by developing a system which would analyze patients’ data, both clinical and molecular.
Before joining Tempus, Lefkofsky had made a reputation for himself as one of the most influential personalities in the tech field in Chicago through his work at Groupon, which he helped start as well. Lefkofsly left his CEO position in Groupon to take a position as the president of Tempus. He, however, still serves as the chairman of Groupon. Beyond these two companies, the 47-year-old has also help co-found other businesses such as Echo Global Logistics, Mediaocean, Innerworkings, and Uptake. He also helped found Lightbank, the capital venture firm based in Chicago.
Eric Lefkofsly has been involved in charity and philanthropy since 2006 when he formed the Lefkofsky Foundation together with his wife. The foundation has helped in the funding of over 50 organizations since inceptions. In 2013, Lefkofsky joined the Giving pledge together with his wife.
To know more visit @: http://www.lightbank.com/team/eric-lefkofsky
Scott M. Rocklage is a renowned chemist and philanthropist. He boasts of massive expertise in healthcare management that goes back to over 30 years ago. He has held top leadership positions and prides himself in leading three drugs to get the FDA approval. These drugs were Omniscan, Teslascan, and Cubicin. He has also guided clinical trials for numerous drug candidates. As an inventor, he holds over 30 patents to his name. Scott has authored and co-authored 100 and more publications that are peer-reviewed. His success can be attributed to the background training in chemistry that he received at two renowned institutes. He obtained a Bachelor of Science degree in chemistry and a Ph.D. in chemistry from the University of California, Berkeley and MIT respectively.
Between 1990 and 1994 Scott Rocklage worked for Nycomed Salutar as the President and business executive. He was the president, chair, CEO for Nycomed Interventional Inc. between 1992 and 1994. Scott then moved to Cubist Pharmaceuticals where he worked as the Founding Executive Officer and President between 1994 and 2003. Scott Rocklage has been involved in numerous ventures holding leadership positions. These companies include Amersham Health, Semprus, Miikana, and Ilypsa Inc. Scott sat on the board of directors of various companies, including Relypsa and Novira Therapeutics. He is currently involved as the Board of Directors Chairman for Rennovia, Cidara Therapeutics Inc., and Kinestral. He is a member of the board of directors for EPIRUS Biopharmaceuticals and Pulmatrix.
Current Role at 5 AM Ventures
5 Am Ventures is an early stage capital company aimed at supporting life science companies. Scott works with scientists, physicians, and other entrepreneurs where he guides them in aligning their business ideas. He helps them optimize their capabilities in solving healthcare needs. Through his organizational and time management skills, he has been able to prioritize the most important tasks. These skills have enabled him to achieve maximum productivity. He has not been afraid of taking risks and has always capitalized on his strengths to grow his business.
Join Scott’s Network: https://www.linkedin.com/in/scott-rocklage-66aa7a12a
Eric Lefkofsky is a philanthropist who has chosen to create a company that serves humanity in a unique way. By redefining how genomic data is used in a clinical setting, Tempus; a technology company, is helping cancer patients by allowing them to benefit from the treatment of others who came before them. By putting together the world’s largest library of clinical and molecular data along with an operating system that allows it to be accessible to physicians, Tempus is helping physicians offer a personalized treatment experience for people who are suffering from cancer. Its data solutions are revolutionizing the industry by allowing physicians to make data-driven, real-time decisions that can completely change the outcome of a cancer patient’s treatment. Click Here for more information.
In his home community of Chicago, Illinois, Eric Lefkofsky sits as a member of many different boards and supports plenty of local charitable causes. Some of the boards he sits on including the board of directors of The Art Institute of Chicago, the board of directors of The Museum of Science and Industry the board of directors at the Children’s Memorial Hospital in Chicago, and the board for World Business Chicago. He supports the local arts by being a Trustee of Steppenwolf Theatre Company, which is a performing arts institution in Chicago.
As a philanthropist, Eric supports numerous causes and organizations, such as the Americans for Responsible Solutions, The Jewish United Fund, Planned Parenthood, The Representation Project, the University of Michigan Health System, the Young Women’s Leadership Charter School, and too many others to mention. His wife and he started up the Lefkofsky Foundation, which has pledged to support scientific, educational, and charitable organizations and causes around the world. Their foundation has funded over 50 organizations to this day and a lot of its focus is aimed at children in need.
Eric Lefkofsky graduated with honors from the University of Michigan and received his Juris Doctor from the University of Michigan Law School.
Visit www.lefkofsky.com for more .